NCI-H2030人非小細(xì)胞肺
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號(hào)
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/2/12 8:41:57
- 訪問(wèn)次數(shù) 14
聯(lián)系方式:陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!
產(chǎn)品名稱: NCI-H2030人非小細(xì)胞肺癌細(xì)胞、 NCI-H2030人非小細(xì)胞肺癌細(xì)胞、 NCI-H2030人非小細(xì)胞肺癌細(xì)胞、 NCI-H2030人非小細(xì)胞肺癌細(xì)胞;
their immune contexture may allow biology driven design of novel immune modulating or immune targeting therapies.Clinical issue: Hepatocellular carcinoma (HCC) is associated with a high mortality rate.
Standard treatment: For many years, sorafenib was the only, and frequently poorly tolerated